Individual and combined prognostic value of LDL-C, Lp(a), and hsCRP for cardiovascular and cerebrovascular events in post-PCI patients: evidence from two large contemporary cohorts
Substantial residual cardiovascular risk persists in patients with coronary artery disease (CAD) despite contemporary secondary prevention. While combined assessment of low-density lipoprotein cholesterol (LDL-C), lipoprotein(a) [Lp(a)], and high-sensitivity C-reactive protein (hsCRP) has demonstrated prognostic...